News

News: Michaels Shares Offering $MIK

The Michaels Companies, Inc., operates a chain of arts and crafts specialty retail stores, has announced that certain of its stockholders (the “Selling Stockholders”) intend to offer for sale 12.5 million shares of its common stock pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission (“SEC”). The Selling Stockholders will receive […]

News: Michaels Shares Offering $MIK Read More »

News: Adamas Enrollment for Parkinson Study $ADMS

Adamas Pharmaceuticals, Inc., has completed the  recruitment of its Phase 3 EASE LID study. EASE LID is a confirmatory trial designed to evaluate the efficacy and safety of ADS-5102 for the treatment of levodopa-induced dyskinesia (LID), a motor complication associated with the treatment of Parkinson’s disease. “This important achievement brings us one step closer to our

News: Adamas Enrollment for Parkinson Study $ADMS Read More »